Abranilla, Baby Girl .
HRN: 26-63-00 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/09/2025
AMPICILLIN 250MG (VIAL)
02/09/2025
02/11/2025
IV
50mg
Q12
Sepsis Neonatorum
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes